1-4 of 4
Detlev Haehling, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Higher Leukemia Free Survival after Post-Induction Hematopoietic Cell Transplantation Compared to Consolidation Therapy in Patients >60 Years with Acute Myelogenous Leukemia (AML): Report from the AML 2004 East German Study Group (OSHO)

Dietger Niederwieser, MD, Haifa Kathrin Al-Ali, MD, Rainer Krahl, PhD, Christoph Kahl, MD, Hans-Heinrich Wolf, MD, Ute Kreibich, MD, Vladan Vucinic, MD, Detlev Haehling, MD, Ute Hegenbart, MD, Alwin Kraemer, Carsten Hirt, MD, Norma Peter, Bernhard Opitz, MD, Axel Florschütz, MD, Kolja Reifenrath, Antje Schulze, MD, Niklas Zojer, MD, Sebastian Scholl, MD, Christian Jakob, MD, Christian Junghanss, MD, Wolfram Pönisch, MD, Simone Heyn, MD, Herbert G. Sayer, MD PhD, Andreas Hochhaus, MD, Thomas Heinicke, MD, Thomas Fischer, MD, Georg Maschmeyer, MD, Peter Dreger, MD
Journal: Blood
Blood (2014) 124 (21): 280.
https://doi.org/10.1182/blood.V124.21.280.280
Published: 2014
Journal Articles

Increasing The Dose Of AraC In Consolidation Therapy Does Not Lead To Higher Overall Survival Or Improved Relapse Incidence In Patients With AML Over The Age Of 60 Years

Dietger Niederwieser, MD, Rainer Krahl, PhD, Christian Jakob, MD, Thomas Heinicke, MD, Christoph Kahl, MD, Antje Schulze, MD, Hans-Heinrich Wolf, MD, Bernhard Opitz, MD, Ute Kreibich, MD, Frank Rothmann, MD, Christian Junghanss, MD, Detlev Haehling, MD, Manfred Schulze, MD, Norma Peter, MD, Ute Hegenbart, MD, Haifa Kathrin Al-Ali, MD, Carsten Hirt, MD, Wolfram Poenisch, MD, Thoralf Lange, Simone Heyn, Vladan Vucinic, Kristina Bartsch, Thomas Fischer, M.D. Ph.D., Georg Maschmeyer, MD, Andreas Hochhaus, MD
Journal: Blood
Blood (2013) 122 (21): 2645.
https://doi.org/10.1182/blood.V122.21.2645.2645
Published: 2013
Journal Articles

Reduction of Relapse Incidence and Improvement of Leukemia Free Survival by Allogeneic Stem Cell Transplantation in Patients with AML and Normal Karyotype Irrespective of the FLT3-ITD Status.

Frank Schueler, MD, Nadezda Basara, MD, Georg Maschmeyer, Thomas Fischer, Michael Herold, Herbert G. Sayer, MD, PhD, Hans-Heinrich Wolf, Ute Kreibich, Detlev Haehling, MD, Gottfried Doelken, MD, Christian Junghanss, MD, Norbert Grobe, Rainer Krahl, Haifa Kathrin Al-Ali, MD, Wolfram Poenisch, Dietger Niederwieser, MD
Journal: Blood
Blood (2009) 114 (22): 1612.
https://doi.org/10.1182/blood.V114.22.1612.1612
Published: 2009
Journal Articles

Cost Evaluation of Rituximab Plus MCP vs. MCP Alone in Advanced Stage Indolent Non-Hodgkin’s-Lymphoma Based on a Randomized Controlled Multicenter Trial.

Klaus Hieke, Rita Pasold, MD, Sabine Neser, MD, Dietger Niederwieser, MD, Andreas Neubauer, MD, Gottfried Doelken, MD, Ralph Naumann, MD, Thomas Fietz, MD, Mathias Freund, MD, Robert Rohrberg, MD, Klaus Hoeffken, MD, Astrid Franke, MD, Thomas-Hein Ittel, MD, Erika Kettner, MD, Ursula Haak, MD, Ullrich Mey, MD, Christian Klinkenstein, MD, M. Assmann, MD, Ullrich von Gruenhagen, MD, Klaus Dachselt, MD, Helga Schwenke, MD, Dorothee Bleyl, MD, Heiner Wolf, MD, Sabine Hahnfels, MD, Franz-Adolph Hoffmann, MD, Volker Lakner, MD, Peter Richter, MD, Detlev Haehling, MD, H.H. Wolf, MD, H. Eschenburg, MD, N. Grobe, MD, M.-R. Clemens, MD, Michael Herold, MD
Journal: Blood
Blood (2004) 104 (11): 87.
https://doi.org/10.1182/blood.V104.11.87.87
Published: 2004